1. Home
  2. Analysis
  3. Magnesium-citrate
  4. Belsomra

Magnesium citrate and Belsomra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium citrate and Belsomra. Common interactions include initial insomnia among females and leukocytosis among males.

The phase IV clinical study analyzes what interactions people who take Magnesium citrate and Belsomra have. It is created by eHealthMe based on reports of 14 people who take Magnesium citrate and Belsomra from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

14 people who take Magnesium citrate and Belsomra together, and have interactions are studied.

What is Magnesium citrate?

Magnesium citrate has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 4,102 Magnesium citrate users for its effectiveness, alternative drugs and more.

What is Belsomra?

Belsomra has active ingredients of suvorexant. It is often used in insomnia. eHealthMe is studying from 11,693 Belsomra users for its effectiveness, alternative drugs and more.

Number of Magnesium citrate and Belsomra reports submitted per year:

Magnesium citrate and Belsomra drug interactions.

Common Magnesium Citrate and Belsomra drug interactions by gender *:

female:

  1. Initial insomnia
  2. Weight increased
  3. Anaemia
  4. Gastric ulcer haemorrhage
  5. Restless legs syndrome
  6. Knee arthroplasty
  7. Mental disorder
  8. Somnolence
  9. Anxiety
  10. Arthralgia

male:

  1. Leukocytosis
  2. Necrotising fasciitis
  3. Renal injury
  4. Renal tubular necrosis
  5. Sepsis
  6. Urinary tract infection
  7. Cellulitis
  8. Groin infection

Common Magnesium Citrate and Belsomra drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Leukocytosis
  2. Necrotising fasciitis
  3. Renal injury
  4. Renal tubular necrosis
  5. Sepsis
  6. Urinary tract infection
  7. Cellulitis
  8. Groin infection

50-59:

  1. Headache
  2. Middle insomnia
  3. Anxiety
  4. Drug ineffective

60+:

  1. Knee arthroplasty
  2. Mental disorder
  3. Somnolence
  4. Arthralgia
  5. Confusional state
  6. Pain
  7. Paraesthesia
  8. Road traffic accident

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 50.00%
  2. Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 28.57%
  3. Type 2 Diabetes: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium citrate and Belsomra?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Magnesium citrate and Belsomra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Magnesium citrate side effects:

Browse all side effects of Magnesium citrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Belsomra side effects:

Browse all side effects of Belsomra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Magnesium citrate interactions:

Browse all interactions between Magnesium citrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Belsomra interactions:

Browse all interactions between Belsomra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on magnesium and suvorexant (the active ingredients of Magnesium citrate and Belsomra, respectively), and Magnesium citrate and Belsomra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Magnesium citrate and Belsomra.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.